Small, strategic bolt-on acquisition that vertically integrates Aurora into the UK market. Monitor upcoming quarterly filings for evidence of EBITDA accretion and UK market share gains. The modest deal size limits immediate stock impact, but successful execution could support a growth narrative in international medical cannabis.
Price Chart
Executive Summary
Aurora Cannabis acquired 100% of Internode Pharma Limited and HAP Pharma Limited for GBP 2.1 million in cash, gaining a licensed UK import/distribution facility and virtual pharmacy. The deal gives Aurora direct control of the UK medical cannabis supply chain and is expected to be accretive to adjusted EBITDA in future quarters, though the upfront cash consideration is small relative to the company's $227M market cap.
Key Facts
- Aurora acquired 100% of Internode Pharma Limited and HAP Pharma Limited
- Total cash consideration of GBP 2.1 million paid to selling shareholders
- Acquisition provides direct ownership of a licensed import/distribution facility and a virtual pharmacy in Birmingham, UK
- Deal gives Aurora end-to-end supply chain control from cultivation to patient delivery in the UK
- Transaction expected to be accretive to adjusted EBITDA contributions in future quarters
- UK has a population of approximately 70 million people and is one of the largest European medical cannabis markets
Financial Impact
GBP 2.1 million cash consideration (approximately $2.7M USD based on typical GBP/USD rate)
Risk Factors
- Integration risk — merging two small UK entities into Aurora's operations may face regulatory or operational hurdles
- UK medical cannabis market remains nascent and regulatory landscape could shift
- Transaction contingent on post-closing conditions — undisclosed earnout or milestone payments could alter final cost
- Forward-looking statements about EBITDA accretion are projections, not guarantees
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001279569-26-000809 |
| Document: aurora_6k.htm | 0001279569-26-000809 |
| Document: 0001279569-26-000809-index-headers.html | 0001279569-26-000809 |
| Document: 0001279569-26-000809-index.html | 0001279569-26-000809 |
| Document: 0001279569-26-000809.txt | 0001279569-26-000809 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | $3.87 | awaiting T+5 | — | $3.90 (+0.78%) |
Oct 14, 2026 12d ago | 6-K | $4.10 $3.97 | ▼ −3.17% | ▼ −2.16% | $3.90 (−4.88%) |
Oct 8, 2026 18d ago | 6-K | $4.43 $4.10 | ▼ −7.45% | ▼ −7.17% | $3.90 (−11.96%) |
Oct 6, 2026 20d ago | 6-K | $4.46 $4.17 | ▼ −6.50% | ▼ −5.52% | $3.90 (−12.56%) |
Oct 5, 2026 21d ago | 6-K | $4.59 $4.29 | ▼ −6.54% | ▼ −6.40% | $3.90 (−15.03%) |
Sep 16, 2026 5w ago | 6-K | $3.83 $4.22 | ▲ +10.18% | ▲ +7.62% | $3.90 (+1.83%) |
Sep 14, 2026 6w ago | 6-K | $3.81 $4.03 | ▲ +5.77% | ▲ +5.67% | $3.90 (+2.36%) |
Sep 9, 2026 6w ago | 6-K | $3.88 $3.83 | ▼ −1.29% | ▼ −0.63% | $3.90 (+0.52%) |
Sep 2, 2026 7w ago | 6-K | $4.03 $3.73 | ▼ −7.44% | ▼ −6.49% | $3.90 (−3.23%) |
Aug 24, 2026 9w ago | 6-K | $3.94 $4.05 | ▲ +2.79% | ▲ +2.32% | $3.90 (−1.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers